Filtered By:
Cancer: Cancer
Therapy: Statin Therapy

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 136 results found since Jan 2013.

Stroke risk 'higher at start of warfarin treatment'
Conclusion This study has found that warfarin was associated with an increased risk of ischaemic stroke during the first 30 days of treatment. After 30 days of treatment, warfarin was associated with a decreased risk of stroke. However, this study has a number of limitations that should be considered: All information was from patient records, which means that it wasn't subject to recall bias, but the information may not be complete – we do not know if, for example, people took the medication they were prescribed. There may be other factors (confounders) that explain the association seen. In particular, the ba...
Source: NHS News Feed - December 19, 2013 Category: Consumer Health News Tags: Heart/lungs Medication Source Type: news

Pre admission treatment with Beta ‐blockers in hypertensive patients with acute stroke and 3‐month outcome—Data from a national stroke registry
In conclusion, treatment with BB is not associated with 3‐month poor outcome in hypertensive patients.
Source: The Journal of Clinical Hypertension - March 9, 2018 Category: Cardiology Authors: Yoav Eizenberg, Ehud Grossman, David Tanne, Silvia Koton Tags: ORIGINAL PAPER Source Type: research

Protective Effects of Different Classes, Intensity, Cumulative Dose-Dependent of Statins Against Primary Ischemic Stroke in Patients with Type 2 Diabetes Mellitus
Curr Atheroscler Rep. 2023 Jul 29. doi: 10.1007/s11883-023-01135-w. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: The aim of this study is to investigate the protective effects of different statin classes, intensity, and cumulative dose-dependent against primary ischemic stroke in patients with T2DM.RECENT FINDINGS: The Cox hazards model was used to evaluate statin use on primary ischemic stroke. Case group: T2DM patients who received statins; control group: T2DM patients who received no statins during the follow-up. Adjusted hazard ratio (aHR) for primary ischemic stroke was 0.45 (95% CI: 0.44 to 0.46). Cox regression ...
Source: Cancer Control - July 29, 2023 Category: Cancer & Oncology Authors: Jung-Min Yu Wan-Ming Chen Ben-Chang Shia Szu-Yuan Wu Source Type: research

Cryptogenic stroke
In about a quarter of ischaemic strokes the cause is undetermined, because the investigation is incomplete or delayed, because there are multiple causes or because the stroke is truly cryptogenic. Cryptogenic stroke can be further classified as non‐embolic or embolic. Embolic stroke of undetermined source can be due to paroxysmal atrial fibrillation, minor emboligenic cardiac conditions, atheroembolism, cancer associated and paradoxical embolism through a patent foramen ovale (PFO) or less often a pulmonary fistula. Currently, risk factor control, statins and antiplatelets are the main therapeutic measures to prevent rec...
Source: European Journal of Neurology - January 18, 2015 Category: Neurology Authors: A. C. Fonseca, J. M. Ferro Tags: Invited Review Source Type: research

UK heart disease and stroke death rates now lower than cancer
Conclusion This valuable research informs on the burden of cardiovascular disease and associated mortality across European countries. It demonstrates that CVD is still the most common cause of death across Europe, but rates have been falling over the past 10 years. This fall means that in several European countries, including the UK, cancer rates now overtake CVD death rates in men. Generally, CVD disability and burden of disease seems to be greater in Eastern European countries. The WHO mortality data and population data are quite up-to-date and should be reliable, though as the researchers say, there was a lack of high ...
Source: NHS News Feed - August 15, 2016 Category: Consumer Health News Tags: Heart/lungs Cancer Neurology Source Type: news

Does a History of Cancer Influence the Effectiveness of Statins on Outcomes After Stroke?
CONCLUSIONS: Treatment with statins after ischemic stroke may confer additional survival benefits for people who also have had cancer.PMID:36065808 | DOI:10.1161/STROKEAHA.122.038829
Source: Atherosclerosis - September 6, 2022 Category: Cardiology Authors: Muideen T Olaiya Nadine E Andrew Lachlan L Dalli David Ung Joosup Kim Vijaya Sundararajan Dominique A Cadilhac Amanda G Thrift Mark R Nelson Leonid Churilov Monique F Kilkenny PRECISE Investigators Source Type: research

Statin Use Postadiation Tied to Significant Stroke Reduction Statin Use Postadiation Tied to Significant Stroke Reduction
Retrospective data show a 32% reduction in stroke and nonsignificant 15% reduction in cardiovascular and cerebrovascular events with postradiation statin therapy for thorax or head or neck cancer.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - July 1, 2019 Category: Neurology Tags: Cardiology News Source Type: news

Statin Use Postradiation Tied to Significant Stroke Reduction Statin Use Postradiation Tied to Significant Stroke Reduction
Retrospective data show a 32% reduction in stroke and nonsignificant 15% reduction in cardiovascular and cerebrovascular events with postradiation statin therapy for thorax or head or neck cancer.Medscape Medical News
Source: Medscape Critical Care Headlines - July 1, 2019 Category: Intensive Care Tags: Cardiology News Source Type: news

RPS assessment of research into effects of lycopene on the risk of heart attack, stroke and cancer
Source: Royal Pharmaceutical Society Area: News The Royal Pharmaceutical Society has featured a report on a small study in which scientists claim a single pill which contains a chemical found in tomato skin (lycopene) could cut the risk of heart attacks, stroke and even slow down the development of cancer.   The two-month study looked at 36 patients with pre-existing heart disease, who were already taking cholesterol-lowering statin drugs, and 36 healthy volunteers. Tests showed that the natural remedy boosts the elasticity and efficiency of blood vessels; in turn this reduces the hardening of the arteries which ...
Source: NeLM - Cardiovascular Medicine - January 8, 2013 Category: Cardiology Source Type: news

Statins May Lower Risk of Stroke After Cancer Radiotherapy
WEDNESDAY, June 19, 2019 -- Radiation treatment for cancer can damage the heart and blood vessels, increasing the risk for a stroke or heart attack. But a new study suggests cholesterol-lowering drugs can significantly reduce that risk. The...
Source: Drugs.com - Daily MedNews - June 19, 2019 Category: General Medicine Source Type: news

Study: Statins reduce stroke risk for cancer patients who received radiation
Cancer patients who took statins to lower cholesterol after radiation treatment for the chest, head or neck saw their stroke risk fall by 32 percent
Source: Health News - UPI.com - June 19, 2019 Category: Consumer Health News Source Type: news

Statins May Lower Risk of Stroke After Cancer Radiotherapy
Title: Statins May Lower Risk of Stroke After Cancer RadiotherapyCategory: Health NewsCreated: 6/19/2019 12:00:00 AMLast Editorial Review: 6/20/2019 12:00:00 AM
Source: MedicineNet Heart General - June 20, 2019 Category: Cardiology Source Type: news

Statins side effects are minimal, study argues
ConclusionThis meta-analysis pooled results from 29 studies and has shown a very small increased risk of newly diagnosed diabetes mellitus. This is the same as the decreased risk of any cause of death in people taking statins, compared to placebo, to prevent a heart attack or stroke.The researchers point out some limitations to the meta-analysis: Each study did not report on all of the side effects, meaning that for each category of side effect, the number of participants differed. The side effect categories were only included if at least 500 people had reported suffering from it. This means there may be numerous other si...
Source: NHS News Feed - March 13, 2014 Category: Consumer Health News Tags: Heart/lungs Medication Source Type: news

Moderate drinking may reduce heart disease risk
Conclusion This study paints a more complicated picture than the "Pint a day keeps the doctor away" story proffered by The Sun. It seems to confirm the findings of other studies, which have shown that non-drinkers tend to have a higher risk of cardiovascular diseases than people who drink moderately. It suggests that some cardiovascular diseases (mainly those directly affecting the heart) seem to have a stronger link to a possible protective effect from alcohol than other vascular diseases, such as mini-strokes and bleeding in the brain. However, this can't be concluded with certainty due to the study design. We ...
Source: NHS News Feed - March 23, 2017 Category: Consumer Health News Tags: Heart/lungs Food/diet Lifestyle/exercise Source Type: news

U.S. Task Force Reconsiders Daily Low-Dose Aspirin Use for Preventing Heart Attacks in Adults Over 60
Older adults without heart disease shouldn’t take daily low-dose aspirin to prevent a first heart attack or stroke, an influential health guidelines group said in preliminary updated advice released Tuesday. Bleeding risks for adults in their 60s and up who haven’t had a heart attack or stroke outweigh any potential benefits from aspirin, the U.S. Preventive Services Task Force said in its draft guidance. For the first time, the panel said there may be a small benefit for adults in their 40s who have no bleeding risks. For those in their 50s, the panel softened advice and said evidence of benefit is less clear....
Source: TIME: Health - October 12, 2021 Category: Consumer Health News Authors: Lindsey Taylor/AP Tags: Uncategorized healthscienceclimate Research wire Source Type: news